The use of lipid-lowering therapies should be considered in paediatric patients at high risk of atherosclerosis

Author：  

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.26, Iss.12, 2010-12, pp. : 9-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenomics of lipid-lowering therapies

By Hu Miao   Tomlinson Brian  

Pharmacogenomics, Vol. 14, Iss. 8, 2013-06 ,pp. : 981-995

Future Medicine

Access to resources Recommend Favorite

Lipid-lowering therapies in development

By Wierzbicki Anthony S  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 11, 2004-11 ,pp. : 1405-1418

Informa Healthcare

Access to resources Recommend Favorite

Hyperlipidaemia in Paediatric Patients: The Role of Lipid-Lowering Therapy in Clinical Practice

By Wierzbicki Anthony S.  

Drug Safety, Vol. 33, Iss. 2, 2010-02 ,pp. : 115-125

Adis International

Access to resources Recommend Favorite

Lipid-Lowering Therapy in Patients with Average Cholesterol and High Cardiovascular Risk, Insights from the Heart Protection Study

By Salam Amar  

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 5, 2004-09 ,pp. : 387-389

Springer Publishing Company

Access to resources Recommend Favorite

Massive benefits for patients at risk of CHD in largest lipid-lowering trial

By  

Inpharma, Vol. 1, Iss. 1317, 2001-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite